The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.
This new study from the author contains 410 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
Report Highlights
Market shares of leading suppliers
Business and technological trends in major markets
Five-year test volume and sales forecasts
Market shares of leading competitors
Feature comparison of major analyzers
Strategic profiles of leading market players and start-up firms developing innovative products
Specific product and business opportunities for instrument and consumable suppliers.
Rationale
Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.
Japan Market Overview
Laboratories performing DNA sequencing and molecular diagnostic testing by country and market segment.
Five-year test volume and sales projections.
Market Segmentation Analysis
Five-year test volume and sales projections.
A comprehensive analysis of the sequencing market by laboratory segment.
Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size, growth and major suppliers.
Product/Technology Review
Comparison of the major molecular diagnostic analyzers.
Extensive review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over target/signal amplification methods.
Worldwide listings of companies, universities and research centers developing new molecular diagnostic technologies and products.
Competitive Assessments
Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
Decode Genetics
Diadexus
Eiken Chemical
Elitech Group
Enzo Biochem
Exact Sciences
Fujirebio
Grifols
Hologic
Illumina
LabCorp
Leica Biosystems
Li-Cor Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
PerkinElmer
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens Healthineers
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher
Comprehensive listings of companies developing and marketing molecular diagnostic products, by test and application.
Opportunities and Strategic Recommendations
Specific new product development opportunities with potentially significant market appeal during the next five years.
DeepL, a global leader in Language AI, has unveiled its latest offering tailored for businesses, DeepL Write Pro. This new release?DeepL's first service powered by its own LLM?changes the game for knowledge workers writing any type of business...
IntelePeer, a leading AI-powered communications automation platform provider, announced today that TMC, a global, integrated media company, has named SmartAgent a 2024 CUSTOMER Product of the Year Award winner.
Driven by generative AI, SmartAgent...
Pagaya Technologies Ltd. ("Pagaya", the "Company" or "we"), a global technology company delivering artificial intelligence infrastructure for the financial ecosystem, today announced that it filed its first annual report on Form 10-K for the year...
JFrog Ltd. ("JFrog") , the Liquid Software company and creators of the JFrog Software Supply Chain Platform, today announced a new machine learning (ML) lifecycle integration between JFrog Artifactory and MLflow, an open source software platform...
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...
Blackline Safety Corp. , a global leader in connected safety technology, today announced the resignation of CFO, Shane Grennan, effective June 30, 2024. After more than eight years as Chief Financial Officer, Mr. Grennan is leaving Blackline to...